Curaleaf Bordentown is the company’s third Garden State location to introduce adult sales
WAKEFIELD, Mass., November 2, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of cannabis consumer products, today announced the launch of sales for adult use on its Bordentown, New Jersey location. Curaleaf Bordentown, located at 191 Route 130, is the company’s third and final location selling adult-use cannabis in the Garden State.
Curaleaf is committed to providing superior products and trusted retail experiences to adult consumers while continuing to serve patients enrolled in the state medical program. Curaleaf Bordentown will continue to prioritize from New Jersey licensed medical patients by providing private consultation areas, a secure online ordering system, exclusive checkout lines and designated parking spaces. To optimize patient accessibility, Curaleaf Bordentown is offering medical patients exclusive shopping hours every day from 8 a.m. to 9 a.m. and 7 p.m. to 8 p.m.
“We are delighted to expand adult use sales to Curaleaf Bordentown, which now enables us to serve both medical and adult customers across our entire New Jersey footprint,” said Matt Darin, CEO of Curaleaf. “Curaleaf is committed to ensuring that our patients and consumers receive quality products and services as they embark on their journey with cannabis. We would like to thank the Town of Bordentown for their continued partnership and for welcoming us into the community. »
According to the New Jersey Cannabis Regulatory Commission, the state generated more than $79 million in recreational cannabis sales of April 21 to June 30. Tax revenue for this period totaled $4.6 million.
Curaleaf Bordentown offers adult customers a wide variety of innovative products, including Select Squeeze, a fast-acting THC drink enhancer, as well as Select’s best-selling Elite Oils and Elite Live. From the company New Jersey The offerings have also recently expanded to include the B NOBLE two-pack pre-rolls.
For more information about Curaleaf locations, patient resources and products in New Jerseyplease visit www.curaleaf.com/dispensary/new-jersey.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer cannabis products whose mission is to improve lives by bringing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for its quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility in medical markets. and adults. In United States, Curaleaf currently operates in 21 states with 142 dispensaries, 26 cultivation sites and employs more than 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, combining pioneering science and research with state-of-the-art cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “proposes”, “plans”, “intends” , “anticipates” or “believes”, or variations of these words and expressions, or by the use of words or expressions indicating that certain actions, events or results can, might, might occur or be achieved. Specifically, and without limitation, this press release contains forward-looking statements and information regarding the introduction of adult use sales at Curaleaf Bordentown. These forward-looking statements and information reflect the current beliefs of management and are based on assumptions made by and information currently available to the company with respect to the subject matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. understood by these statements. Additional information on these assumptions and risks and uncertainties is contained in the “Risk Factors and Uncertainties” section of the Company’s most recently filed Annual Information Form. March 9, 2022, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other documents the Company has filed and may file with applicable securities authorities in the future . The forward-looking statements contained herein are made only as of the date of this press release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place significant reliance on any forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved of the contents of this press release.
Curaleaf Holdings, Inc.
Camille LyonInvestment Director
Curaleaf Holdings, Inc.
Tracy Bradysenior vice president of corporate communications
View original content: https://www.prnewswire.com/news-releases/curaleaf-expands-new-jersey-adult-use-sales-to-bordentown-dispensary-301665886.html
SOURCE Curaleaf Holdings, Inc.
. Curaleaf expands sales for adults in Jersey dispensary Bordentown